$PVSP While December through February are traditionally the slowest quarter of the year in Cannabis, and on the heels of an industry wide post pandemic contraction, Pervasip is reporting 2.4% growth in revenue over last year’s comparative First Quarter, markedly improved gross margins and positive EBITDA.